Global Drugs for Anti-Infective Market Research Report 2026(Status and Outlook)

May 2026 | 115 pages | ID: G4A642ED9283EN
Bosson Research

Abstracts

Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.The Anti-Infective Drugs market refers to the pharmaceuticals and medications used for the treatment of infectious diseases caused by bacteria, viruses, fungi, or parasites. This market encompasses various therapeutic areas such as antibiotics, antivirals, antifungals, and antiparasitics. The Anti-Infective Drugs market has been witnessing steady growth due to factors such as the increasing prevalence of infectious diseases, the emergence of drug-resistant strains, and the growing global population. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, but the market in Asia Pacific is expected to witness substantial growth in the coming years.

The global Drugs for Anti-Infective market size was estimated at USD 229480.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.40% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Drugs for Anti-Infective market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Drugs for Anti-Infective market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drugs for Anti-Infective market.

Global Drugs for Anti-Infective Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• GlaxoSmithKline
• Merck
• Pfizer
• Novartis AG
• Gilead Sciences
• Abbott
• Sanofi-Aventis
• Bristol-Myers Squibb
• Johnson
• Roche Pharma AG
• Nanosphere
• NanoViricides
• Novabay Pharmaceuticals
• Obetech
• Optimer Pharmaceuticals
• Basilea Pharmaceutica AG
• Daiichi Sankyo

Market Segmentation (by Type)

• OTC
• Rx Drugs

Market Segmentation (by Application)

• Hospital
• Drugs Store
• Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Drugs for Anti-Infective Market

Overview of the regional outlook of the Drugs for Anti-Infective Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drugs for Anti-Infective Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Drugs for Anti-Infective, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Drugs for Anti-Infective
1.2 Key Market Segments
  1.2.1 Drugs for Anti-Infective Segment by Type
  1.2.2 Drugs for Anti-Infective Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 DRUGS FOR ANTI-INFECTIVE MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 DRUGS FOR ANTI-INFECTIVE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Drugs for Anti-Infective Product Life Cycle
3.3 Global Drugs for Anti-Infective Revenue Market Share by Company (2020-2025)
3.4 Drugs for Anti-Infective Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Drugs for Anti-Infective Market Competitive Situation and Trends
  3.6.1 Drugs for Anti-Infective Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Drugs for Anti-Infective Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 DRUGS FOR ANTI-INFECTIVE VALUE CHAIN ANALYSIS

4.1 Drugs for Anti-Infective Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF DRUGS FOR ANTI-INFECTIVE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Drugs for Anti-Infective Market Porter's Five Forces Analysis

6 DRUGS FOR ANTI-INFECTIVE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drugs for Anti-Infective Market by Type (2020-2025)
6.3 Global Drugs for Anti-Infective Market Size Growth Rate by Type (2021-2025)

7 DRUGS FOR ANTI-INFECTIVE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drugs for Anti-Infective Market Size (M USD) by Application (2020-2025)
7.3 Global Drugs for Anti-Infective Market Size Growth Rate by Application (2021-2025)

8 DRUGS FOR ANTI-INFECTIVE MARKET SEGMENTATION BY REGION

8.1 Global Drugs for Anti-Infective Market Size by Region
  8.1.1 Global Drugs for Anti-Infective Market Size by Region
  8.1.2 Global Drugs for Anti-Infective Market Size Market Share by Region
8.2 North America
  8.2.1 North America Drugs for Anti-Infective Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Drugs for Anti-Infective Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Spain
8.4 Asia Pacific
  8.4.1 Asia Pacific Drugs for Anti-Infective Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Drugs for Anti-Infective Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Drugs for Anti-Infective Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 GlaxoSmithKline
  9.1.1 GlaxoSmithKline Basic Information
  9.1.2 GlaxoSmithKline Drugs for Anti-Infective Product Overview
  9.1.3 GlaxoSmithKline Drugs for Anti-Infective Product Market Performance
  9.1.4 GlaxoSmithKline SWOT Analysis
  9.1.5 GlaxoSmithKline Business Overview
  9.1.6 GlaxoSmithKline Recent Developments
9.2 Merck
  9.2.1 Merck Basic Information
  9.2.2 Merck Drugs for Anti-Infective Product Overview
  9.2.3 Merck Drugs for Anti-Infective Product Market Performance
  9.2.4 Merck SWOT Analysis
  9.2.5 Merck Business Overview
  9.2.6 Merck Recent Developments
9.3 Pfizer
  9.3.1 Pfizer Basic Information
  9.3.2 Pfizer Drugs for Anti-Infective Product Overview
  9.3.3 Pfizer Drugs for Anti-Infective Product Market Performance
  9.3.4 Pfizer SWOT Analysis
  9.3.5 Pfizer Business Overview
  9.3.6 Pfizer Recent Developments
9.4 Novartis AG
  9.4.1 Novartis AG Basic Information
  9.4.2 Novartis AG Drugs for Anti-Infective Product Overview
  9.4.3 Novartis AG Drugs for Anti-Infective Product Market Performance
  9.4.4 Novartis AG Business Overview
  9.4.5 Novartis AG Recent Developments
9.5 Gilead Sciences
  9.5.1 Gilead Sciences Basic Information
  9.5.2 Gilead Sciences Drugs for Anti-Infective Product Overview
  9.5.3 Gilead Sciences Drugs for Anti-Infective Product Market Performance
  9.5.4 Gilead Sciences Business Overview
  9.5.5 Gilead Sciences Recent Developments
9.6 Abbott
  9.6.1 Abbott Basic Information
  9.6.2 Abbott Drugs for Anti-Infective Product Overview
  9.6.3 Abbott Drugs for Anti-Infective Product Market Performance
  9.6.4 Abbott Business Overview
  9.6.5 Abbott Recent Developments
9.7 Sanofi-Aventis
  9.7.1 Sanofi-Aventis Basic Information
  9.7.2 Sanofi-Aventis Drugs for Anti-Infective Product Overview
  9.7.3 Sanofi-Aventis Drugs for Anti-Infective Product Market Performance
  9.7.4 Sanofi-Aventis Business Overview
  9.7.5 Sanofi-Aventis Recent Developments
9.8 Bristol-Myers Squibb
  9.8.1 Bristol-Myers Squibb Basic Information
  9.8.2 Bristol-Myers Squibb Drugs for Anti-Infective Product Overview
  9.8.3 Bristol-Myers Squibb Drugs for Anti-Infective Product Market Performance
  9.8.4 Bristol-Myers Squibb Business Overview
  9.8.5 Bristol-Myers Squibb Recent Developments
9.9 Johnson
  9.9.1 Johnson Basic Information
  9.9.2 Johnson Drugs for Anti-Infective Product Overview
  9.9.3 Johnson Drugs for Anti-Infective Product Market Performance
  9.9.4 Johnson Business Overview
  9.9.5 Johnson Recent Developments
9.10 Roche Pharma AG
  9.10.1 Roche Pharma AG Basic Information
  9.10.2 Roche Pharma AG Drugs for Anti-Infective Product Overview
  9.10.3 Roche Pharma AG Drugs for Anti-Infective Product Market Performance
  9.10.4 Roche Pharma AG Business Overview
  9.10.5 Roche Pharma AG Recent Developments
9.11 Nanosphere
  9.11.1 Nanosphere Basic Information
  9.11.2 Nanosphere Drugs for Anti-Infective Product Overview
  9.11.3 Nanosphere Drugs for Anti-Infective Product Market Performance
  9.11.4 Nanosphere Business Overview
  9.11.5 Nanosphere Recent Developments
9.12 NanoViricides
  9.12.1 NanoViricides Basic Information
  9.12.2 NanoViricides Drugs for Anti-Infective Product Overview
  9.12.3 NanoViricides Drugs for Anti-Infective Product Market Performance
  9.12.4 NanoViricides Business Overview
  9.12.5 NanoViricides Recent Developments
9.13 Novabay Pharmaceuticals
  9.13.1 Novabay Pharmaceuticals Basic Information
  9.13.2 Novabay Pharmaceuticals Drugs for Anti-Infective Product Overview
  9.13.3 Novabay Pharmaceuticals Drugs for Anti-Infective Product Market Performance
  9.13.4 Novabay Pharmaceuticals Business Overview
  9.13.5 Novabay Pharmaceuticals Recent Developments
9.14 Obetech
  9.14.1 Obetech Basic Information
  9.14.2 Obetech Drugs for Anti-Infective Product Overview
  9.14.3 Obetech Drugs for Anti-Infective Product Market Performance
  9.14.4 Obetech Business Overview
  9.14.5 Obetech Recent Developments
9.15 Optimer Pharmaceuticals
  9.15.1 Optimer Pharmaceuticals Basic Information
  9.15.2 Optimer Pharmaceuticals Drugs for Anti-Infective Product Overview
  9.15.3 Optimer Pharmaceuticals Drugs for Anti-Infective Product Market Performance
  9.15.4 Optimer Pharmaceuticals Business Overview
  9.15.5 Optimer Pharmaceuticals Recent Developments
9.16 Basilea Pharmaceutica AG
  9.16.1 Basilea Pharmaceutica AG Basic Information
  9.16.2 Basilea Pharmaceutica AG Drugs for Anti-Infective Product Overview
  9.16.3 Basilea Pharmaceutica AG Drugs for Anti-Infective Product Market Performance
  9.16.4 Basilea Pharmaceutica AG Business Overview
  9.16.5 Basilea Pharmaceutica AG Recent Developments
9.17 Daiichi Sankyo
  9.17.1 Daiichi Sankyo Basic Information
  9.17.2 Daiichi Sankyo Drugs for Anti-Infective Product Overview
  9.17.3 Daiichi Sankyo Drugs for Anti-Infective Product Market Performance
  9.17.4 Daiichi Sankyo Business Overview
  9.17.5 Daiichi Sankyo Recent Developments

10 DRUGS FOR ANTI-INFECTIVE MARKET FORECAST BY REGION

10.1 Global Drugs for Anti-Infective Market Size Forecast
10.2 Global Drugs for Anti-Infective Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Drugs for Anti-Infective Market Size Forecast by Country
  10.2.3 Asia Pacific Drugs for Anti-Infective Market Size Forecast by Region
  10.2.4 South America Drugs for Anti-Infective Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Sales of Drugs for Anti-Infective by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

11.1 Global Drugs for Anti-Infective Market Forecast by Type (2026-2035)
  11.1.1 Global Drugs for Anti-Infective Market Size Forecast by Type (2026-2035)
11.2 Global Drugs for Anti-Infective Market Forecast by Application (2026-2035)
  11.2.1 Global Drugs for Anti-Infective Market Size (M USD) Forecast by Application (2026-2035)

12 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drugs for Anti-Infective Market Size by Type (M USD)
Table 4. Global Drugs for Anti-Infective Market Size by Application
Table 5. Drugs for Anti-Infective Market Size Comparison by Region (M USD)
Table 6. Global Drugs for Anti-Infective Revenue (M USD) by Company (2020-2025)
Table 7. Global Drugs for Anti-Infective Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Anti-Infective as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Drugs for Anti-Infective Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Drugs for Anti-Infective Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Drugs for Anti-Infective Market Size by Type (M USD)
Table 22. Global Drugs for Anti-Infective Market Size (M USD) by Type (2020-2025)
Table 23. Global Drugs for Anti-Infective Market Share by Type (2020-2025)
Table 24. Global Drugs for Anti-Infective Market Size Growth Rate by Type (2021-2025)
Table 25. Global Drugs for Anti-Infective Market Size by Application
Table 26. Global Drugs for Anti-Infective Market Size by Application (2020-2025) & (M USD)
Table 27. Global Drugs for Anti-Infective Market Share by Application (2020-2025)
Table 28. Global Drugs for Anti-Infective Market Size Growth Rate by Application (2021-2025)
Table 29. Global Drugs for Anti-Infective Market Size by Region (2020-2025) & (M USD)
Table 30. Global Drugs for Anti-Infective Market Size Market Share by Region (2020-2025)
Table 31. North America Drugs for Anti-Infective Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Drugs for Anti-Infective Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Drugs for Anti-Infective Market Size by Region (2020-2025) & (M USD)
Table 34. South America Drugs for Anti-Infective Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Drugs for Anti-Infective Market Size by Region (2020-2025) & (M USD)
Table 36. GlaxoSmithKline Basic Information
Table 37. GlaxoSmithKline Drugs for Anti-Infective Product Overview
Table 38. GlaxoSmithKline Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 39. GlaxoSmithKline SWOT Analysis
Table 40. GlaxoSmithKline Business Overview
Table 41. GlaxoSmithKline Recent Developments
Table 42. Merck Basic Information
Table 43. Merck Drugs for Anti-Infective Product Overview
Table 44. Merck Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Merck SWOT Analysis
Table 46. Merck Business Overview
Table 47. Merck Recent Developments
Table 48. Pfizer Basic Information
Table 49. Pfizer Drugs for Anti-Infective Product Overview
Table 50. Pfizer Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Pfizer SWOT Analysis
Table 52. Pfizer Business Overview
Table 53. Pfizer Recent Developments
Table 54. Novartis AG Basic Information
Table 55. Novartis AG Drugs for Anti-Infective Product Overview
Table 56. Novartis AG Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Novartis AG Business Overview
Table 58. Novartis AG Recent Developments
Table 59. Gilead Sciences Basic Information
Table 60. Gilead Sciences Drugs for Anti-Infective Product Overview
Table 61. Gilead Sciences Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Recent Developments
Table 64. Abbott Basic Information
Table 65. Abbott Drugs for Anti-Infective Product Overview
Table 66. Abbott Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Abbott Business Overview
Table 68. Abbott Recent Developments
Table 69. Sanofi-Aventis Basic Information
Table 70. Sanofi-Aventis Drugs for Anti-Infective Product Overview
Table 71. Sanofi-Aventis Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Sanofi-Aventis Business Overview
Table 73. Sanofi-Aventis Recent Developments
Table 74. Bristol-Myers Squibb Basic Information
Table 75. Bristol-Myers Squibb Drugs for Anti-Infective Product Overview
Table 76. Bristol-Myers Squibb Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb Recent Developments
Table 79. Johnson Basic Information
Table 80. Johnson Drugs for Anti-Infective Product Overview
Table 81. Johnson Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Johnson Business Overview
Table 83. Johnson Recent Developments
Table 84. Roche Pharma AG Basic Information
Table 85. Roche Pharma AG Drugs for Anti-Infective Product Overview
Table 86. Roche Pharma AG Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Roche Pharma AG Business Overview
Table 88. Roche Pharma AG Recent Developments
Table 89. Nanosphere Basic Information
Table 90. Nanosphere Drugs for Anti-Infective Product Overview
Table 91. Nanosphere Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Nanosphere Business Overview
Table 93. Nanosphere Recent Developments
Table 94. NanoViricides Basic Information
Table 95. NanoViricides Drugs for Anti-Infective Product Overview
Table 96. NanoViricides Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 97. NanoViricides Business Overview
Table 98. NanoViricides Recent Developments
Table 99. Novabay Pharmaceuticals Basic Information
Table 100. Novabay Pharmaceuticals Drugs for Anti-Infective Product Overview
Table 101. Novabay Pharmaceuticals Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Novabay Pharmaceuticals Business Overview
Table 103. Novabay Pharmaceuticals Recent Developments
Table 104. Obetech Basic Information
Table 105. Obetech Drugs for Anti-Infective Product Overview
Table 106. Obetech Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Obetech Business Overview
Table 108. Obetech Recent Developments
Table 109. Optimer Pharmaceuticals Basic Information
Table 110. Optimer Pharmaceuticals Drugs for Anti-Infective Product Overview
Table 111. Optimer Pharmaceuticals Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Optimer Pharmaceuticals Business Overview
Table 113. Optimer Pharmaceuticals Recent Developments
Table 114. Basilea Pharmaceutica AG Basic Information
Table 115. Basilea Pharmaceutica AG Drugs for Anti-Infective Product Overview
Table 116. Basilea Pharmaceutica AG Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Basilea Pharmaceutica AG Business Overview
Table 118. Basilea Pharmaceutica AG Recent Developments
Table 119. Daiichi Sankyo Basic Information
Table 120. Daiichi Sankyo Drugs for Anti-Infective Product Overview
Table 121. Daiichi Sankyo Drugs for Anti-Infective Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Daiichi Sankyo Business Overview
Table 123. Daiichi Sankyo Recent Developments
Table 124. Global Drugs for Anti-Infective Market Size Forecast by Region (2026-2035) & (M USD)
Table 125. North America Drugs for Anti-Infective Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Europe Drugs for Anti-Infective Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Asia Pacific Drugs for Anti-Infective Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Drugs for Anti-Infective Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Middle East and Africa Drugs for Anti-Infective Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Global Drugs for Anti-Infective Market Size Forecast by Type (2026-2035) & (M USD)
Table 131. Global Drugs for Anti-Infective Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Industry Chain of Drugs for Anti-Infective
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drugs for Anti-Infective Market Size (M USD), 2025-2035
Figure 5. Global Drugs for Anti-Infective Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drugs for Anti-Infective Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Drugs for Anti-Infective Product Life Cycle
Figure 12. Global Drugs for Anti-Infective Revenue Share by Company in 2025
Figure 13. Drugs for Anti-Infective Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Drugs for Anti-Infective Revenue in 2025
Figure 15. Value Chain Map of Drugs for Anti-Infective
Figure 16. Global Drugs for Anti-Infective Market PEST Analysis
Figure 17. Global Drugs for Anti-Infective Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Drugs for Anti-Infective Market Share by Type
Figure 20. Market Share of Drugs for Anti-Infective by Type (2020-2025)
Figure 21. Global Drugs for Anti-Infective Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drugs for Anti-Infective Market Share by Application
Figure 24. Global Drugs for Anti-Infective Market Share by Application (2020-2025)
Figure 25. Global Drugs for Anti-Infective Market Share by Application in 2024
Figure 26. Global Drugs for Anti-Infective Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Drugs for Anti-Infective Market Size Market Share by Region (2020-2025)
Figure 28. North America Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Drugs for Anti-Infective Market Size Market Share by Country in 2024
Figure 30. U.S. Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Drugs for Anti-Infective Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Drugs for Anti-Infective Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Drugs for Anti-Infective Market Share by Country in 2024
Figure 35. Germany Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Drugs for Anti-Infective Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Drugs for Anti-Infective Market Size Market Share by Region in 2024
Figure 42. China Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Drugs for Anti-Infective Market Size and Growth Rate (M USD)
Figure 48. South America Drugs for Anti-Infective Market Size Market Share by Country in 2024
Figure 49. Brazil Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Drugs for Anti-Infective Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Drugs for Anti-Infective Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Drugs for Anti-Infective Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Drugs for Anti-Infective Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Drugs for Anti-Infective Market Share Forecast by Type (2026-2035)
Figure 61. Global Drugs for Anti-Infective Market Share Forecast by Application (2026-2035)